{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:06:24Z","timestamp":1759341984438},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ejim.2005.11.011","type":"journal-article","created":{"date-parts":[[2006,4,16]],"date-time":"2006-04-16T11:09:48Z","timestamp":1145185788000},"page":"163-169","source":"Crossref","is-referenced-by-count":13,"title":["Promising new therapies for Behcet's disease"],"prefix":"10.1016","volume":"17","author":[{"given":"M.H.","family":"Houman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2005.11.011_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002281-200401000-00008","article-title":"Beh\u00e7et syndrome","volume":"16","author":"Yurdakul","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib2","first-page":"512","article-title":"History and development of Behcet's disease","volume":"63","author":"Dilsen","year":"1996","journal-title":"Rev Rhum [Engl Ed]"},{"key":"10.1016\/j.ejim.2005.11.011_bib3","first-page":"488","article-title":"Epidemiology of Adamantiades\u2013Behcet's disease","volume":"150","author":"Zouboulis","year":"1999","journal-title":"Ann Med Interne [Paris]"},{"key":"10.1016\/j.ejim.2005.11.011_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","article-title":"Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51","volume":"60","author":"Direskeneli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2005.11.011_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.1990.tb05122.x","article-title":"Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behcet's disease","volume":"79","author":"Hamzaoui","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2005.11.011_bib6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Behcet's disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ejim.2005.11.011_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/0-306-48382-3_44","article-title":"MICA transmembrane region polymorphism and HLA B51 in Tunisian Behcet's disease patients","volume":"528","author":"Ben Ahmed","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejim.2005.11.011_bib8","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet's disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Beh\u00e7et's disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2005.11.011_bib10","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib11","first-page":"CD001084","article-title":"Pharmacotherapy for Behcet's syndrome","author":"Saenz","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2005.11.011_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-002-0023-z","article-title":"Behcet's disease: immunopathologic and therapeutic aspects","volume":"4","author":"Meador","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ejim.2005.11.011_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0021-5155(99)00029-5","article-title":"Epidemiological features and visual prognosis of Beh\u00e7et's disease","volume":"43","author":"Ando","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ejim.2005.11.011_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","article-title":"Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy","volume":"106","author":"Kotake","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2005.11.011_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon \u03b1 in Behcet disease: review of the literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","article-title":"Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behcet disease: results of an open 4-center trial","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","article-title":"Treatment of Adamantiades\u2013Beh\u00e7et disease with systemic interferon alfa","volume":"134","author":"Zouboulis","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib18","unstructured":"Hamza M. The long-term treatment with interferon-alfa2a in Beh\u00e7et's Disease: Seventh International Conference on Beh\u00e7et's Disease, Pub Adhoua, Tunis, Tunisia; 1997."},{"key":"10.1016\/j.ejim.2005.11.011_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.1999.59","article-title":"Ocular complications with high-dose interferon alpha in chronic active hepatitis","volume":"13","author":"Kadayifcilar","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.ejim.2005.11.011_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002770050255","article-title":"Beh\u00e7et's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Beh\u00e7et's symptoms","volume":"74","author":"Budak-Alpdogan","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2005.11.011_bib21","first-page":"S6","article-title":"Beh\u00e7et's disease: an update on the pathogenesis","volume":"19","author":"Gul","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor alphain clinical uveitis","volume":"33","author":"Santos Lacomba","year":"2001","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.ejim.2005.11.011_bib23","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib24","first-page":"185","article-title":"The treatment of recurrent uveitis with TNF-alpha inhibitors","volume":"56","author":"Falappone","year":"2004","journal-title":"Reumatismo"},{"key":"10.1016\/j.ejim.2005.11.011_bib25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/41.10.1213-b","article-title":"Behcet's syndrome: response to infliximab after failure of etanercept","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatology [Oxford]"},{"key":"10.1016\/j.ejim.2005.11.011_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight threatening panuveitis in Behcet's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2005.11.011_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.11204","article-title":"Treatment with infliximab for a child with Behcet's disease","volume":"49","author":"Saulsburg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2005.11.011_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.61.3.283-a","article-title":"Remission of Behcet's syndrome with TNF alpha blocking treatment","volume":"61","author":"Rozenbaum","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2005.11.011_bib30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joesph","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2005.11.011_bib31","first-page":"S422","article-title":"A prospective trial of infliximab therapy from patients with refractory uveitis: preliminary results","volume":"48","author":"Suhler","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2474-4-19","article-title":"Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report","volume":"4","author":"Gulli","year":"2003","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ejim.2005.11.011_bib33","first-page":"S181","article-title":"Treatment of refractory vitritis in Beh\u00e7et disease with infliximab","volume":"46","author":"Arayssi","year":"2002","journal-title":"Arthritis Rheum Abstr"},{"issue":"suppl 2","key":"10.1016\/j.ejim.2005.11.011_bib34","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Behcet's disease: a new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2005.11.011_bib35","first-page":"S181","article-title":"The response of treatment resistant uveitis in Behcet's syndrome [BS] to a TNF-a blocker, etanercept: an open study","volume":"46","author":"Melikoglu","year":"2002","journal-title":"Arthritis Rheum Abstr"},{"key":"10.1016\/j.ejim.2005.11.011_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","article-title":"Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab","volume":"40","author":"Robertson","year":"2001","journal-title":"Rheumatology [Oxford]"},{"key":"10.1016\/j.ejim.2005.11.011_bib37","first-page":"1241","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/112067210401400515","article-title":"Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behcet disease","volume":"14","author":"Giansanti","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ejim.2005.11.011_bib39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1345\/aph.1D361","article-title":"Effect of infliximab on refractory uveitis in Behcet's disease","volume":"38","author":"Sayarlioglu","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"140","key":"10.1016\/j.ejim.2005.11.011_bib40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades\u2013Behcet disease","volume":"2","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2005.11.011_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10350-004-6506-4","article-title":"Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody [infliximab] therapy: report of a case","volume":"46","author":"Kram","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejim.2005.11.011_bib42","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2003.010975","article-title":"Successful treatment of genital ulcers with infliximab in Behcet's disease","volume":"63","author":"Haugeberg","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2005.11.011_bib43","first-page":"S57","article-title":"Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behcet's disease","volume":"21","author":"Andonopoulos","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib44","first-page":"181","article-title":"Successful treatment of long-standing Neuro-Beh\u00e7et's disease with infliximab","volume":"32","author":"Sarwar","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/0-306-48382-3_113","article-title":"Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades\u2013Behcet's disease","volume":"528","author":"Behrens","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejim.2005.11.011_bib46","first-page":"358","article-title":"Effect of infliximab on threatening panuveitis in Behcet's disease","author":"Munoz-Fernandez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2005.11.011_bib47","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2001.29035","article-title":"Transmembrane TNF-a, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease","volume":"121","author":"Van Deventer","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2005.11.011_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/02713688108998359","article-title":"S antigen-induced experimental autoimmune uveo-retinitis in rats","volume":"1","author":"De Kozak","year":"1981","journal-title":"Curr. Eye Res"},{"key":"10.1016\/j.ejim.2005.11.011_bib49","first-page":"1296","article-title":"Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein","volume":"27","author":"Gery","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejim.2005.11.011_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9394(14)71070-0","article-title":"Treatment of uveitis by oral administration of retinal antigens: results of a phase I\/II randomised masked trial","volume":"123","author":"Nussenblatt","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2005.11.011_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-2478(99)00071-1","article-title":"Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis","volume":"68","author":"Thurau","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ejim.2005.11.011_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","article-title":"Oral tolerization with peptide 336\u2013351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease","volume":"137","author":"Stanford","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2005.11.011_bib53","first-page":"69","article-title":"Autologous hematopoietic stem-cell transplantation for Beh\u00e7et's disease with pulmonary involvement","volume":"344","author":"Breitbart","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2005.11.011_bib54","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2003-10-3617","article-title":"Autologous hematopoietic stem cell transplantation for severe\/refractory intestinal Behcet disease","volume":"103","author":"Rossi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2005.11.011_bib55","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/keg424","article-title":"Remission induction in Behcet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H","volume":"42","author":"Lockwood","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2005.11.011_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00126839-200304010-00002","article-title":"Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: a randomised, double-blind, placebo-controlled study","volume":"4","author":"Matsuda","year":"2003","journal-title":"Drugs R D"},{"key":"10.1016\/j.ejim.2005.11.011_bib57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archderm.135.5.529","article-title":"The use of sucralfate suspension in the treatment of oral and genital ulceration of Beh\u00e7et disease: a randomized, placebo-controlled, double-blind study","volume":"135","author":"Alpsoy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Behcet's disease a double-blind, placebo-controlled study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2005.11.011_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejim.2005.11.011_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1991.tb05883.x","article-title":"Treatment of Behcet's disease with indometacin","volume":"30","author":"Simsek","year":"1991","journal-title":"Int J Dermatol"},{"issue":"356","key":"10.1016\/j.ejim.2005.11.011_bib62","article-title":"Methotrexate for cular lesions of Behcet's disease. Cohort study on 262 patients","volume":"41","author":"Davatchi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib63","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.11.011_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Beh\u00e7et's disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ejim.2005.11.011_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporine A versus pulsed cyclophosphamide in Beh\u00e7et's syndrome: a single masked trial","volume":"76","author":"\u00d6zyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ejim.2005.11.011_bib66","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2005.11.011_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08830189709116844","article-title":"Immunotherapy for Behcet's disease","volume":"14","author":"Mochizuki","year":"1997","journal-title":"Intern Rev Immunol"},{"issue":"7","key":"10.1016\/j.ejim.2005.11.011_bib68","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0248-8663(02)00621-5","article-title":"Les manifestations neurologiques de la maladie de Beh\u00e7et: \u00e9tude de 27 cas","volume":"23","author":"Houman","year":"2002","journal-title":"Rev M\u00e9d Int"},{"key":"10.1016\/j.ejim.2005.11.011_bib69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Beh\u00e7et's disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejim.2005.11.011_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","article-title":"Chlorambucil in the treatment of uveitis and meningoencephalitis of Beh\u00e7et's disease","volume":"76","author":"O'Duffy","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2005.11.011_bib71","first-page":"587","article-title":"Vena cava thrombosis in Beh\u00e7et's disease. Analysis of a series of 10 cases","volume":"150","author":"Houman","year":"1999","journal-title":"Ann Med Interne"},{"issue":"Suppl. 24","key":"10.1016\/j.ejim.2005.11.011_bib72","first-page":"S48","article-title":"Deep vein thrombosis in Behcet's disease","volume":"19","author":"Houman","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2005.11.011_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0272-5231(01)00014-4","article-title":"Pulmonary complications of Beh\u00e7et's disease","volume":"23","author":"Erkan","year":"2002","journal-title":"Clin Chest Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620506000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620506000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T01:25:18Z","timestamp":1555550718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620506000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0953620506000100"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2005.11.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}